Evidence map›Paper›PMID 20883684›Full record

ArticleDevelopmental biology2011

Fibroblast growth factor 10 represses premature cell differentiation during establishment of the intestinal progenitor niche.

Pia Nyeng, Maureen Ann Bjerke, Gitte Anker Norgaard, Xiaoling Qu, Sune Kobberup, Jan Jensen

Abstract read
In one paragraph

Article in Developmental biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Fibroblast growth factor 10 alters the balance between goblet and Paneth cells in the adult mouse small intestine.American journal of physiology. Gastrointestinal and liver physiology · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Pia NyengBarbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 1775 N Ursula St. B140, 80045 Aurora, CO, USA. Pia.Nyeng@med.lu.se
Maureen Ann Bjerke
Gitte Anker Norgaard
Xiaoling Qu
Sune Kobberup
Jan Jensen
University of Colorado Anschutz Medical Campus · USCleveland Clinic · USUniversity of Colorado Health · US

Funding

UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2000 to 2010
$14.0M
Proteomic/Genomic Analysis of the Developing PancreasU19DK061248 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2001 to 2004
$4.8M
Molecular mechanism of FGF10 signaling in pancreatic developmentR01DK070636 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JENSEN, JAN · 2005 to 2008
$1.1M
Molecular mechanism of FGF10 signaling in pancreatic developmentR56DK070636 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI JENSEN, JAN · 2010 to 2010
$236k
NIDDK NIH HHS DK070636NIDDK NIH HHS P30 DK057516NIDDK NIH HHS P30 DK57516NIDDK NIH HHS R01 DK070636NIDDK NIH HHS R56 DK070636NIDDK NIH HHS U19 DK061248
6 · The paper itself

Abstract

Spatio-temporal regulation of the balance between cell renewal and cell differentiation is of vital importance for embryonic development and adult homeostasis. Fibroblast growth factor signaling relayed from the mesenchyme to the epithelium is necessary for progenitor maintenance during organogenesis of most endoderm-derived organs, but it is still ambiguous whether the signal is exclusively mitogenic. Furthermore, the downstream mechanisms are largely unknown. In order to elucidate these questions we performed a complementary analysis of fibroblast growth factor 10 (Fgf10), gain-of-function and loss-of-function in the embryonic mouse duodenum, where the progenitor niche is clearly defined and differentiation proceeds in a spatially organized manner. In agreement with a role in progenitor maintenance, FGF10 is expressed in the duodenal mesenchyme during early development while the cognate receptor FGFR2b is expressed in the epithelial progenitor niche. Fgf10 gain-of-function in the epithelium leads to spatial expansion of the progenitor niche and repression of cell differentiation, while loss-of-function results in premature cell differentiation and subsequent epithelial hypoplasia. We conclude that FGF10 mediated mesenchymal-to-epithelial signaling maintains the progenitor niche in the embryonic duodenum primarily by repressing cell differentiation, rather than through mitogenic signaling. Furthermore, we demonstrate that FGF10-signaling targets include ETS-family transcription factors, which have previously been shown to regulate epithelial maturation and tumor progression.

Indexed as

Cell DifferentiationSignal TransductionAnimalsCell ProliferationEmbryonic Stem CellsFibroblast Growth Factor 10Gene Expression Regulation, DevelopmentalIntestinal MucosaIntestinesMiceMice, TransgenicReceptor, Fibroblast Growth Factor, Type 2Fgf10 protein, mouseFibroblast Growth Factor 10Receptor, Fibroblast Growth Factor, Type 2

Identifiers

PMID20883684
PMCPMC4312005
OpenAlexW2105445260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.